NDC 50419-407
Beyaz
Drospirenone/ethinyl Estradiol/levomefolate Calcium And Levomefolate Calcium
Beyaz is a Kit in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is .
| Product ID | 50419-407_48187a64-36c9-428c-a71e-623241bf19f4 |
| NDC | 50419-407 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Beyaz |
| Generic Name | Drospirenone/ethinyl Estradiol/levomefolate Calcium And Levomefolate Calcium |
| Dosage Form | Kit |
| Marketing Start Date | 2010-10-07 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022532 |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 50419-407-00
90 BLISTER PACK in 1 PACKAGE (50419-407-00) > 1 KIT in 1 BLISTER PACK
| Marketing Start Date | 2010-10-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50419-407-03 [50419040703]
Beyaz KIT
| Marketing Category | NDA |
| Application Number | NDA022532 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-10-07 |
NDC 50419-407-70 [50419040770]
Beyaz KIT
| Marketing Category | NDA |
| Application Number | NDA022532 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-10-07 |
NDC 50419-407-00 [50419040700]
Beyaz KIT
| Marketing Category | NDA |
| Application Number | NDA022532 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-10-07 |
NDC 50419-407-01 [50419040701]
Beyaz KIT
| Marketing Category | NDA |
| Application Number | NDA022532 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-10-08 |
NDC 50419-407-71 [50419040771]
Beyaz KIT
| Marketing Category | NDA |
| Application Number | NDA022532 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-10-08 |
NDC 50419-407-75 [50419040775]
Beyaz KIT
| Marketing Category | NDA |
| Application Number | NDA022532 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-10-07 |
Drug Details
OpenFDA Data
| SPL SET ID: | 8132454a-6135-4bac-b206-83a55eb8dbc6 |
| Manufacturer | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Medicade Reported Pricing
50419040703 BEYAZ 28 TABLET
Pricing Unit: EA | Drug Type:
50419040701 BEYAZ 28 TABLET
Pricing Unit: EA | Drug Type:
NDC Crossover Matching brand name "Beyaz" or generic name "Drospirenone/ethinyl Estradiol/levomefolate Calcium And Levomefolate Calcium"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50419-407 | Beyaz | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium |
| 0781-4075 | Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium |
| 0781-4103 | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium |
| 50419-403 | Safyral | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium |
Trademark Results [Beyaz]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BEYAZ 77893906 3938786 Live/Registered |
Bayer Aktiengesellschaft 2009-12-15 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.